Michael Narkewicz, MD, FAASLD

Biography

Michael R. Narkewicz, MD, FAASLD
Professor of Pediatrics
Section of Pediatric Gastroenterology, Hepatology and Nutrition
Department of Pediatrics, University of Colorado School of Medicine
Executive for Strategic Provider Partnerships, Children's Hospital Colorado

Michael R. Narkewicz, MD, earned his medical degree from the University of Vermont in 1983. He completed his Pediatric Residency training at the University of Colorado School of Medicine in 1986. In 1989, he completed his Fellowship in Pediatric Gastroenterology and Nutrition at the University of Colorado School of Medicine.

Dr. Narkewicz joined the faculty of the Department of Pediatrics at the University of Colorado School of Medicine and Children's Hospital Colorado in 1989. He was appointed Professor of Pediatrics in 2003 and was awarded tenure in 2015. He is boarded in Pediatrics, Pediatric Gastroenterology and Pediatric Transplant Hepatology and is a Fellow of the American Association for the Study of Liver Disease.

Dr. Narkewicz is nationally recognized for his expertise in pediatric hepatology and liver transplantation. His research interests include clinical studies in children with cystic fibrosis liver disease, pediatric chronic viral hepatitis biliary atresia, Fontan associated liver disease, hematologic and immunologic complications following pediatric liver transplantation, and clinical trials in acute liver failure and cystic fibrosis liver disease. Dr. Narkewicz is Principal Investigator of the Cystic Fibrosis Liver Disease Network leading 3 studies focused on identifying markers to predict the development of advanced CF liver disease including PUSH, ELASTIC and a proteomic study. He was the senior author on the new CF foundation guidelines for Screening, Monitoring and Management of Liver Involvement in CF.